AVEO Pharmaceuticals Inc. (AVEO)
NASDAQ: AVEO
· Real-Time Price · USD
15.00
0.00 (0.00%)
At close: Jan 19, 2023, 10:00 PM
AVEO Pharmaceuticals Revenue
AVEO Pharmaceuticals reported an annual revenue of $38.87M, reflecting a 545.85% growth. For the quarter ending September 30, 2022, AVEO Pharmaceuticals generated $30.45M in revenue.
Revenue (ttm)
38.87M
Revenue Growth
545.85%
Price / Sales Ratio
4.15
Revenue / Employee
341K
Employees
114
Market Cap
0
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2021 | 38.87M | +545.85% |
| Dec 31, 2020 | 6.02M | -79.10% |
| Dec 31, 2019 | 28.8M | +432.35% |
| Dec 31, 2018 | 5.41M | -28.63% |
| Dec 31, 2017 | 7.58M | +201.35% |
| Dec 31, 2016 | 2.52M | -86.78% |
| Dec 31, 2015 | 19.02M | +4.97% |
| Dec 31, 2014 | 18.12M | +1301.62% |
| Dec 31, 2013 | 1.29M | -93.30% |
| Dec 31, 2012 | 19.29M | -88.30% |
| Dec 31, 2011 | 164.85M | +268.94% |
| Dec 31, 2010 | 44.68M | +115.66% |
| Dec 31, 2009 | 20.72M | +5.38% |
| Dec 31, 2008 | 19.66M | +78.18% |
| Dec 31, 2007 | 11.03M | n/a |